The global Artificial Pancreas Device Systems Market is expected to reach US$ 2,168.1 Mn in 2025 from US$ 481.8 Mn in 2017. The market is estimated to grow with a CAGR of 20.9% from 2016-2025.
Driving factors such as, growing prevalence of diabetes, developments by major players, rise in demand for computerized systems for glycemic control are expected to boost the market growth over the years. In addition, increasing medical tourism in emerging nations are likely to have a positive impact on the growth of the global artificial pancreas device systems market in the coming years. However, availability of alternatives for artificial pancreas device systems and high cost associated with these systems are likely to negatively affect the market growth in the coming years. On the other hand, use of pancreas cell implant is expected to be one of the prevalent trends in the market. Use of an artificial pancreas is related to the better control of blood sugar levels for people with type 1 diabetes compared with standa
